A Study of DS-1471a In Subjects With Advanced Solid Tumors

Stopped early · Phase 1

Conditions studied: Advanced Solid Tumor

In brief

This first-in-human (FIH) study will assess the safety, preliminary efficacy, pharmacokinetics (PK), and immunogenicity of DS-1471a in participants with advanced or metastatic solid tumors.

Key facts

Study ID

NCT06074705

Run by

Daiichi Sankyo Co., Ltd.

People needed

17

Starts

2023-08-04

Expected to finish

2025-07-29

Last updated by the study team

2025-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Florida Cancer Specialist — Sarasota, Florida, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States
• National Cancer Center Hospital East — Chiba, Japan
• National Cancer Center Hospital — Tokyo, Japan
• The Cancer Institute Hospital of JFCR — Tokyo, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.